Bioequivalence Studies
Our bioequivalence studies are designed to demonstrate therapeutic equivalence between generic and reference pharmaceutical products. We conduct single-dose and steady-state studies across various formulations including tablets, capsules, transdermal patches, and complex generics.
- –FDA-inspected facility with proven track record
- –Studies conducted per ICH, FDA, EMA, and WHO guidelines
- –200+ successfully completed BE studies
- –Fast turnaround times with flexible scheduling



